A detailed history of Versant Capital Management, Inc transactions in Grifols Sa stock. As of the latest transaction made, Versant Capital Management, Inc holds 3,112 shares of GRFS stock, worth $27,105. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,112
Previous 5,598 44.41%
Holding current value
$27,105
Previous $55,000 50.91%
% of portfolio
0.0%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 08, 2026

SELL
$8.36 - $10.02 $20,782 - $24,909
-2,486 Reduced 44.41%
3,112 $27,000
Q3 2025

Oct 27, 2025

BUY
$8.87 - $10.85 $14,050 - $17,186
1,584 Added 39.46%
5,598 $55,000
Q2 2025

Jul 07, 2025

BUY
$6.49 - $9.09 $661 - $927
102 Added 2.61%
4,014 $36,000
Q1 2025

Apr 03, 2025

BUY
$6.62 - $8.71 $25,897 - $34,073
3,912 New
3,912 $27,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.91B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.